Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
about
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Growth-differentiation factor ...... ulation Therapy (RE-LY) trial.
@en
type
label
Growth-differentiation factor ...... ulation Therapy (RE-LY) trial.
@en
prefLabel
Growth-differentiation factor ...... ulation Therapy (RE-LY) trial.
@en
P2093
P50
P1476
Growth-differentiation factor ...... ulation Therapy (RE-LY) trial.
@en
P2093
Jonas Oldgren
Michael D Ezekowitz
Paul A Reilly
Stuart J Connolly
Ulrika Andersson
Ziad Hijazi
P304
P356
10.1016/J.AHJ.2017.06.001
P407
P577
2017-06-06T00:00:00Z